1. The Field of the Invention
The present invention relates generally to apparatus and methods for the suturing of body lumens. More particularly, the present invention relates to techniques for percutaneous closure of arterial and venous puncture sites, which are usually accessed through a tissue tract.
2. The Relevant Technology
A number of diagnostic and interventional vascular procedures are now performed translumenally. A catheter is introduced to the vascular system at a convenient access location and guided through the vascular system to a target location using established techniques. Such procedures require vascular access, which is usually established during the well-known Seldinger technique, as described, for example, in William Grossman's “Cardiac Catheterization and Angioplasty,” 3rd Ed., Lea and Febiger, Philadelphia, 1986, incorporated herein by reference. Vascular access is generally provided through an introducer sheath, which is positioned to extend from outside the patient body into the vascular lumen.
When vascular access is no longer required, the introducer sheath is removed and bleeding at the puncture site stopped. One common approach for providing hemostasis (the cessation of bleeding) is to apply external force near and upstream from the puncture site, typically by manual or “digital” compression. This approach suffers from a number of disadvantages. It is time consuming, frequently requiring one-half hour or more of compression before hemostasis is assured. Additionally, such compression techniques rely on clot formation, which can be delayed until anticoagulants used in vascular therapy procedures (such as for heart attacks, stent deployment, non-optical PTCA results, and the like) wear off. This can take two to four hours, thereby increasing the time required before completion of the compression technique. The compression procedure is further uncomfortable for the patient and frequently requires analgesics to be tolerable. Moreover, the application of excessive pressure can at times totally occlude the underlying blood vessel, resulting in ischemia and/or thrombosis. Following manual compression, the patient typically remains recumbent from four to as much as twelve hours or more under close observation so as to assure continued hemostasis. During this time renewed bleeding may occur, resulting in blood loss through the tract, hematoma and/or pseudo-aneurysm formation, as well as arteriovenous fistula formation. These complications may require blood transfusion and/or surgical intervention.
The incidence of complications from compression-induced hemostasis increases when the size of the introducer sheath grows larger, and/or when the patient is anticoagulated. It is clear that the compression technique for arterial closure can be risky, and is expensive and onerous to the patient. Although the risk of complications can be reduced by using highly trained individuals, dedicating such personnel to this task is both expensive and inefficient. Nonetheless, as the number and efficacy of translumenally performed diagnostic and interventional vascular procedures increases, the number of patients requiring effective hemostasis for a vascular puncture continues to increase.
To overcome the problems associated with manual compression, the use of bioabsorbable fasteners or sealing bodies to stop bleeding has previously been proposed. Generally, these approaches rely on the placement of a thrombogenic and bioabsorbable material, such as collagen, at the superficial arterial wall over the puncture site. While potentially effective, this approach suffers from a number of problems. It can be difficult to properly locate the interface of the overlying tissue and the adventitial surface of the blood vessel. Locating the fastener too far from that interface can result in failure to provide hemostasis, and subsequent hematoma and/or pseudo-aneurysm formation. Conversely, if the sealing body intrudes into the arterial lumen, intravascular clots and/or collagen pieces with thrombus attached can form and embolize downstream, causing vascular occlusion. Also, thrombus formation on the surface of a sealing body protruding into the lumen can cause a stenosis, which can obstruct normal blood flow. Other possible complications include infection, as well as adverse reaction to the collagen or other implant.
A more effective approach for vascular closure has been proposed in U.S. Pat. Nos. 5,417,699, 5,613,974; and PCT published Patent Application No. PCT/US96/10271 filed on Jun. 12, 1996, the full disclosures of which are incorporated herein by reference. A suture-applying device is introduced through the tissue tract with a distal end of the device extending through the vascular puncture. One or more needles in the device are then used to draw suture through the blood vessel wall on opposite sides of the puncture, and the suture is secured directly over the adventitial surface of the blood vessel wall to provide highly reliable closure.
While a significant improvement over the use of manual pressure, clamps, and collagen plugs, certain design criteria have been found to be desirable for successful suturing to achieve vascular closure. For example, it is highly beneficial to properly direct the needles through the blood vessel wall at a significant distance from the puncture so that the suture is well anchored in the tissue and can provide tight closure. It is also highly beneficial to insure that the needle deployment takes place when the device is properly positioned relative to the vessel wall. The ease of deployment and efficacy of the procedure can further be enhanced by reducing the cross-section of that portion of the device, which is inserted into the tissue tract and/or the vessel itself, which may also allow closure of the vessel in a relatively short amount of time without imposing excessive injury to the tissue tract or vessel.
For the above reasons, it would be desirable to provide improved devices, systems, and methods for suturing vascular punctures. The new device should have the capability of delivering a pre-tied knot to an incision site. It would be particularly beneficial if these improved devices provided some or all of the benefits while overcoming one or more of the disadvantages discussed above.
The present invention provides improved devices, systems, and methods for suturing of body lumens. The device often allows the suturing of vascular puncture sites located at the distal end of a percutaneous tissue tract with greater ease, in less time, and with less patient trauma than known systems. Vascular puncture site suturing can be generally provided through the use of shafts having smaller cross-sections than prior suturing systems. In the exemplary embodiment, an elongate articulated foot near a distal end of a shaft can be inserted through the penetration and actuated so that the foot extends along the lumenal axis. The foot can carry suture attachment cuffs, and can be drawn proximally up against the endothelial surface of the blood vessel. Needles can be advanced from the shaft, through the vessel wall beyond the penetration, and into engagement with the needle cuffs. The cross-section of the shaft within the tissue tract can be minimized by laterally deflecting the needles before they leave the shaft, while tapered depressions within the foot can help guide the advancing needles into engagement with the cuffs. The cuffs can lockingly engage the needles so that the cuffs can be withdrawn proximally along the needle paths through the tissue tract so as to form a loop of suture across the puncture without having to thread the needles directly with the suture inside the blood vessel. The suture loop may be drawn distally from the shaft, proximally from within the blood vessel, or laterally down one of the needle paths, across the puncture, and out the opposing path. The interior of the shaft can be configured to aid with releasing the suture loop. More generally, the interior of the shaft can include one or more friction reducing structures or structures that reduce the frictional engagement between the portion of the device forming the slot and the flexible filament.
Regardless, the articulating foot may be realigned with the shaft and withdrawn proximally through the tissue tract in a small profile configuration. The use of an articulatable foot in combination with lateral deflection of the needles can avoid dilation of the tissue tract, as was often necessary using known puncture closure systems.
In one configuration, the invention can provide a method for suturing a puncture through a vessel wall of a blood vessel. The puncture can be disposed within a tissue tract of a patient body, and the method can comprise attaching a flexible filament to a first fitting. The first fitting can be inserted through the tissue tract and positioned adjacent the vessel wall, and a needle path can be formed by advancing a first needle through the vessel wall. The needle can be coupled with the first fitting, and the first needle, the first fitting, and at least a portion of the filament can be withdrawn through the vessel wall along the needle path.
First and second fittings can often be coupled to the flexible filament, and can generally be positioned so that the puncture can be disposed therebetween. The flexible filament can often comprise a suture extending between the first and second fittings, with each fitting being drawn proximally by an associated needle so as to form the suture loop. Alternatively, at least one of the needles may include a detachable tip and may advance a suture distally along the needle path as the needle penetrates through the vessel wall. The flexible filament can again couple the first and second fittings, here allowing both fittings to be withdrawn along a single needle path so that the suture advances down along the first needle path, laterally across the puncture, and then out the other needle path.
Positioning of the fittings can be generally effected by articulating an elongate foot within the blood vessel so that the foot extends along the vessel axis. A confirmation lumen may extend along a shaft supporting the foot to ensure that the foot is positioned within the vessel prior to articulation. Once the foot is properly articulated, it can be withdrawn to firmly engage the endothelial layer of the vessel. The foot can include tapering depressions, which direct the advancing needle toward the fitting, and the suture or other flexible filament adjacent the fittings can be releasably restrained within a narrow slot extending from the depression. This slot can optionally include one or more friction reducing structures or structures that reduce the frictional engagement between the portion of the device forming the slot and the flexible filament.
The suture or other flexible filament and its associated slot can be arranged to avoid entanglement of the advancing needle in the suture, and to ensure that the fitting and suture can be withdrawn proximally as the needle is refracted. An atraumatic, flexible monorail guidebody may extend from the shaft and/or the articulatable foot to facilitate alignment of the foot with the vessel, and also to help provide hemostasis while the knot is tied. A wide variety of foot articulation mechanisms may be provided, with deployment optionally being effected when the foot is disposed entirely within the vessel and using an actuator and foot motion that avoid dilation of the puncture.
In another configuration, the invention can provide a method for suturing an opening in a tissue. The method can comprise inserting a distal end of a device through the opening, the device defining a device axis. An elongated foot of the device can be articulated so that first and second ends of the foot extend laterally with the opening aligned therebetween. A first needle path can be formed from the device, through the tissue, and to the first end of the foot. A second needle path can be formed from the device, through the tissue, and to the second end of the foot. Suture can be advanced along the first and second needle paths to position a suture loop across the opening.
These and other objects and features of the present invention will become more fully apparent from the following description and appended claims, or may be learned by the practice of the invention as set forth hereinafter.
To further clarify the above and other advantages and features of the present invention, a more particular description of the invention will be rendered by reference to specific embodiments thereof which are illustrated in the appended drawings. It is appreciated that these drawings depict only typical embodiments of the invention and are therefore not to be considered limiting of its scope. The invention will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:
A suturing device, which delivers a pre-tied knot to an incision, is disclosed. As an overview, a suturing device in accordance with the present invention includes a first penetrator having a pre-tied knot disposed thereabout and a second penetrator having suture disposed thereon. During operation of the suturing device, the first penetrator and the second penetrator penetrate the tissue about a periphery of an incision in a body lumen. Upon penetration, a penetrator tip releasably engaged with the first penetrator couples with a foot of the suturing device. As the first and second penetrators retract from the body lumen, the penetrator tip and the suture coupled with the penetrator tip retract through a penetration formed in the body lumen by the first penetrator. As will be discussed in greater detail with reference to the accompanying Figures, as the suture retracts, the pre-tied knot receives the suture, forming a knot for suturing the incision in the body lumen.
Referring now to
As can be seen with reference to
Actuation of foot 24 is illustrated more clearly in
Actuation of foot handle 26 slides a foot actuation wire 32 proximally, pulling foot 24 from a parked position to the deployed position illustrated in
Shaft 12 also includes a foot position verification lumen that extends distally from a position verification port 36 to a position indicator at housing 18. When the foot is properly positioned within the blood vessel, blood pressure will cause blood to flow proximally through the indicator lumen to the indicator. The indicator may optionally comprise a blood exit port, a clear receptacle in which blood is visible, or the like. In the exemplary embodiment, the indicator of handle 18 comprises a length of clear tubing extending from housing 18 (not shown) in which the blood is clearly visible. It should be understood that a wide variety of alternative position verifications sensors might be used, including electrical pressure sensors, electrolytic fluid detectors, or the like.
The structures used in positioning a loop of suture across the puncture can be understood with reference to
To facilitate attachment of fitting 40 to suture 34, a second slot cut in the tubular fitting structure defines a suture attachment collar 50. Optionally, collar 50 may be crimped about suture 34 to mechanically affix the suture to fitting 40. In addition and/or instead of mechanical crimping, suture 34 may be bonded to fitting 40 using an adhesive, heat, fasteners, knots, or the like.
Fitting 40 is quite small in size, and is generally configured to facilitate withdrawing the fitting (and the attached suture) along with needle 38 axially through the vessel wall along the needle path. Needle 38 can generally have a cross-sectional width of between about 0.010 inches and 0.020 inches. Barb 42 can extend laterally so as to define an engagement surface 44 having a protruding length of between about 0.002 inches and 0.005 inches. Fitting 40 can have a cross-sectional size roughly corresponding to or only slightly larger than needle 38. Fitting 40 can have an outer lateral width of between about 0.014 inches and 0.025 inches, and an axial length of between about 0.035 inches and 0.050 inches. Channel 46 can be sized to receive at least a portion of needle 38, and can generally have a width of between about 0.010 inches and 0.020 inches. Suture 34 can extend axially opposite the open end of channel 46 so as to minimize drag when the suture is drawn proximally along the needle path. In the exemplary embodiment, needle 38 has a diameter of about 0.020 inches, while the fitting comprises a tube having an outer diameter of about 0.020 inches, an inner diameter of about 0.016 inches, and an overall length of about 0.047 inches. The fitting can comprise a resilient material, optionally comprising a metal, and in the exemplary embodiment, comprising stainless steel.
Needles 38 typically have a length of between about 5.0 inches and 6.0 inches, and can be sufficiently stiff to be advanced in compression through the vessel wall (and adjacent tissues) for up to 0.5 inches when supported in cantilever. Nonetheless, the needles can be flexible enough to be laterally deflected within shaft 12, as can be understood with reference to
As was generally described above, foot 24 includes needle receptacles 52 adjacent the ends of the foot. A fitting 40 (with an associated end of suture 34) is disposed within each needle receptacle and a surface of the receptacle tapers proximally and outwardly so as to guide the advancing needles 38 into engagement with fittings 40 when foot 24 is in the deployed position. As fittings 40 (and associated portions of suture 34) are releasably supported in the foot, needles 38 can be withdrawn proximally so as to draw the fittings and suture ends from the foot proximally into (and optionally through) shaft 12. The needle receptacles of the exemplary embodiment taper outward at an angle between 20 and 35 degrees from the centerline of fitting 40, and the fitting is held in a recess having a diameter of about 0.0230 inches and a length of about 0.042 inches. A lateral opening or window through the side of foot to the fitting recess may be provided to facilitate needle and/or cuff positioning during assembly of the device, and a protruding collar near the proximal end of the fitting recess may help keep the fitting in position.
One example of a suitable structure and articulation motion for foot 24 is illustrated in
Referring now to
The suture slot 58, or a portion thereof, can be configured to reduce the frictional engagement or contact between the suture and the foot 24. For example, and with reference to
As illustrated, the raised portions 86 define a first inner diameter id1, while the recessed portions 88 define a second inner diameter id2. In the illustrated configuration, the id1 can be about 0.030 inches, while id2 can any diameter greater than the id1, for instance about 0.040 inches. It will be understood by those skilled in the art that various other configurations are possible. For example, although the raised portions 86 and the recessed portions 88 are generally uniformly distributed on the interior surface 84 in an alternating fashion, irregular distribution of the portions 86 and 88 is possible. Further, although the portions 86 and 88 are generally depicted as being uniform in size, shape, or general configuration, non-uniform size, shape, or configuration of portions 86 and 88 are possible. In addition, the id1 and id2 can be any desired diameter greater or lesser than those identified herein. For instance, and not by way of limitation, id1 can be greater or lesser than 0.030 inches, while id2 can be greater or lesser than 0.040 inches, so long as id2 is greater than id1.
While the above discussion regarding structures to reduce frictional contact is directed to reducing frictional contact between the sutures and the slot of the foot, it will be understood by those skilled in the art that structure similar to those described herein can be used in any portion of the device that may obtain a benefit from reducing the frictional contact with the suture. For instance, and not by way of limitation, portions of the shaft or lumen of the shaft, tubular members disposed within a lumen of the shaft or integrally formed with the shaft, the handle, the guidebody, the foot, or any other portion of the device, or other devices described herein may also include lumens or slots that include friction reducing structures.
A wide variety of foot actuation mechanisms might be used within the scope of the present invention. A first alternative foot actuation arrangement is illustrated in
A still further alternative foot actuation mechanism is illustrated in
Yet another foot actuation mechanism can be understood with reference to
A variety of features may be included in the articulatable foot, the needle receptacle, and/or the needle to avoid tangling of the needle in the suture as the needle is directed to the fitting. As illustrated in
An alternative mechanism for avoiding entanglement of the needle with the suture is illustrated in
A still further alternative mechanism for avoiding entanglement between the suture and the needle is illustrated in
An alternative vessel closure device 70 will be explained with reference to
Referring now to
Bight 80 can define a knot when first end suture passes therethrough, as can be understood with reference to FIGS. 11Ai and 11Aii. Bight 80 can often include more than one loop, and may be pre-arranged so as to define a square knot (using the layout schematically illustrated in FIG. 11Ai), a clinch knot (FIG. 11Aii), or a variety of known or new surgical knots.
Device 70 advances along tissue tract TT to puncture P in blood vessel V. Once foot 24 is disposed within a blood vessel V, a pull wire moves the foot proximally and pivots the foot laterally so that the foot extends along an axis A of the vessel, as illustrated in
As can be understood with reference to
It will be recognized that removal of device 70 can be facilitated by coupling first end 76 to bight 80 over an outer surface of the device, and by arranging suture 34 and hollow needle 38′ so that the suture can pull free of the needle when detachable tip 78 is released, for example, by having the suture exit the needle proximally of the tip through a channel that extends to the tip so that the needle does not encircle the suture. By including such provisions, after foot 24 is returned to the narrow configuration, the device can be pulled proximally from the tissue tract leaving the pre-tied knot in place.
Alternative arrangements (using the detachable needle ends of device 70) are possible to provide the benefit of a pre-tied knot and the like for closure of a vessel puncture. For example, a device having a pair of needles in which each needle included a detachable tip might be used to pull first end 76 through a bight, so that the bight need not encircle the needle path of one of the needles.
It will be understood that hollow needle 38′ can be modified to aid with the slidable engagement of the suture with the interior of the lumen of the hollow needle 38′. For instance, and not by way of limitation, the lumen of hollow need 38′, or other portion of the suture path, can include friction reducing structures as described in
In some cases, particularly for closure of large punctures, it may be advantageous to provide multiple suture loops across the puncture, either in parallel, in an “X” pattern, or the like. As illustrated in
The method of use of the devices of
Deployment of the foot is effected by actuation of the foot deployment handle, as described and illustrated above with reference to
Referring now to
To facilitate easy removal from within the guidebody 22 or a lumen of the shaft 12, friction reducing structures can be formed within guidebody 22 or the lumen of shaft 12. Exemplary structures are illustrated in
It will be understood by those skilled in the art that various other configurations of the friction reducing structures are possible. For example, although the raised portions 86′ and the recessed portions 88′ are generally uniformly distributed on the interior surface 84′ in an alternating fashion, irregular distribution of the portions 86′ and 88′ is possible. Further, although the portions 86′ and 88′ are generally depicted as being uniform in size, shape, or general configuration, non-uniform size, shape, or configuration of portions 86′ and 88′ are possible.
While the above discussion regarding structures to reduce frictional contact is directed to reducing frictional contact between the sutures and the slot of the foot, it will be understood by those skilled in the art that structure similar to those described herein can be used in any portion of the device that may obtain a benefit from reducing the frictional contact with the suture. For instance, and not by way of limitation, portions of the shaft or lumen of the shaft, tubular members disposed within a lumen of the shaft or integrally formed with the shaft, the handle, the guidebody, the foot, or any other portion of the device, or other devices described herein may also include lumens or slots that include friction reducing structures.
Referring now to
Now referring to
The articulatable foot 114 includes anterior and posterior penetrator receptacles 116′ and 116, respectively. These receptacles are also referred to as cuff pockets. Cuffs 110 are shown positioned in cuff pockets 116′ and 116. A link 112 extends between the cuffs 110.
As may be seen with reference to
When both the elongate bodies 106 and 106′ and the suture 102 pass through the lumen wall W and into the lumen 107, the elongate bodies 106 and 106′ engage with the foot 114. The penetrator tip 108 and anterior penetrator tip 108′ of the elongate bodies 106 and 106′ engage with cuffs 110 and 110′ of the foot 114. The cuffs 110 and 110′ include a link 112 that connects the cuffs 110 and 110′ to one another. It should be noted that the cuffs 110 and 110′ facilitate connection of the penetrator tip 108 with the anterior penetrator tip 108′ such that the penetrator tip 108 and the anterior penetrator tip 108′ are coupled to one another via the link 112.
The ends of the suture may be distinguished from each other by changing the color of one end (e.g. with dye), providing an attachment on one end (e.g. shrink wrap tubing, a bead, etc.) or with the suture itself (e.g. tying a knot in one end).
Referring to
As the suture loop 103 and the suture 102 move, the pre-tied suture knot 104 also moves in the same direction as the suture loop 103 towards the foot 114 and the incision. The suture loop 103 continues to move the pre-tied suture knot 104 towards the incision until the suture 102 and the pre-tied suture knot 104 suture the incision formed in the arterial wall. It should be noted that a suture trimmer might be used to assist the delivery of the knot 104 to an arteriotomy. The suture trimmer may be any device suitable for pushing the knot towards the arteriotomy and trimming suture immediately adjacent the knot 104 once the knot is tightened.
Now making reference to
The ends may be distinguished from each other by changing the color of one end (e.g. with dye), providing an attachment on one end (e.g. shrink wrap tubing, a bead, etc.) or with the suture itself (e.g. tying a knot in on end).
With reference to
As illustrated, the plurality of raised portions 344 define a first inner diameter id1, while the plurality of recessed portions 346 define a second inner diameter id2. With an outside diameter (od1) of the elongated body 306, id1 can be about 0.030 inches, while id2 can any diameter between the od1 and the id1. In the illustrated configuration, the id2 can be between about 0.040 inches and about 0.030 inches. It will be understood by those skilled in the art that various other configurations are possible. For example, although the raised portions 344 and the recessed portions 346 are generally uniformly distributed on the interior surface 346 irregular distribution of the portions 344 and 346 is possible. Further, although the portions 344 and 346 are generally depicted as being uniform in size, shape, or general configuration, non-uniform size, shape, or configuration of portions 344 and 346 possible.
Returning to
Once the penetrator tip 308 engages with the cuff 310, the elongate body 306 and the penetrator tip 308, along with the cuff 310, proceed through the foot 314 and into the lumen 307. As may be seen with reference to
As shown in
In another embodiment shown in
In yet another alternate embodiment shown in
It should be noted that other methods might be used to detach the penetrator tip 308 from the elongate body 306. These methods include, but are not limited to, detachment through friction or tension. Making reference to
After detachment, during retraction of the elongate body 306 and the elongate body 306′ (not shown), the link 312 may draw the cuff 310 and the penetrator tip 308 from the cuff pocket 316. As discussed earlier, the cuff 310′ engages with the elongate body 306′ and pulls the cuff 310 via the link 312 as the elongate body 306′ refracts from the lumen 307. As such, retracting the link 312 pulls on the cuff 310, thereby pulling the cuff 310 from the cuff pocket 316 and through the lumen 307 along with the suture 302, as shown with respect to
An example of one body capable of storing the suture 302 is illustrated in
The illustrated interior surface 342′ can include at least two portions having differing diameters; at least one raised portion 344′ and at least one recessed portion 346′, optionally a plurality of raised portions 344′ and a plurality of recessed portions 346′, optionally in an alternating configuration, which extend longitudinally along the length of the elongated body 306′. The combination of the raised portions 344′ and recessed portions 346′ reduce the contact surface between the suture 302 (
As illustrated, the plurality of raised portions 344′ define a first inner diameter id1, while the plurality of recessed portions 346′ define a second inner diameter id2. With an outside diameter (od1) of the suture storage tube 301′, id1 can be about 0.030 inches, while id2 can any diameter between the od1 and the id1. In the illustrated configuration, the id2 can be between about 0.040 inches and about 0.030 inches. It will be understood by those skilled in the art that various other configurations are possible. For example, although the raised portions 344′ and the recessed portions 346′ are generally uniformly distributed on the interior surface 346′ irregular distribution of the portions 344′ and 346′ is possible. Further, although the portions 344′ and 346′ are generally depicted as being uniform in size, shape, or general configuration, non-uniform size, shape, or configuration of portions 344′ and 346′ possible.
Embodiments of the suturing device of the invention may also include additional configurations for a foot, as shown with reference to
In an embodiment of the present invention where the suturing device 300 employs the foot 319, during use of the suturing device 300, upon insertion of the suturing device 300 within the lumen 307, a user deploys the foot 319 as shown with reference to
Another embodiment of the suturing device 300 includes feet 324 and 328 as shown with reference to
During use of a suturing device implementing the feet 324 and 328, a user inserts the suturing device into an incision as the foot 328 resides within the foot 324. Upon insertion of the suturing device within the incision, the user deploys the feet 324 and 328 by moving the feet 324 and 328 towards the cam surfaces 326a, in order to deploy the feet 324 and 328, as previously described. After deployment of the feet 324 and 328 within a lumen, the user deploys the elongate bodies 306 and 306′ whereby the penetrator tip 308 and needle tip 308′ engage with the cuffs 310 and 310′ residing within the cuff pockets 324a and 328a. Upon engagement with the cuffs 310 and 310′ the user retracts the elongate bodies 306 and 306′ and sutures the incision.
In addition to the alternative configurations for the foot of the suturing device 300, the suturing device 300 may also include alternative cuff configurations that allow engagement of the elongate bodies 306 and 306′ with the link 312. An example of such an alternative configuration is shown with respect to
Referring to
In another embodiment, the suturing device 300 may also employ a clip and ring assembly 338 which couples the elongate bodies 306 and 306′ with the link 312, as shown with reference to
The clip and ring assembly 338 also includes a ring 334 that engages with the clip 336. The link 312 couples with the ring 334 using any suitable technique, such as tying or the like. The ring 334 has a circular configuration as shown with respect to
Referring to
To assemble the link and cuff assembly, a length of link material is first threaded through the cuff. The end of the link material extending from the penetrator tip receiving end 434 of the cuff 410 is then heated so that it expands. The link is then pulled through the cuff 410 such that the expanded end portion 442 is seated in the interior tapered end 432 of the cuff 410.
The various embodiments of the suturing device may include any of a variety of types of suture, such as braided or monofilament. The suture material may be absorbable or nonabsorbable and may be made of polyester, polypropylene, polyglycolic acid, nylon, silk or any of a variety of suture materials known in the art. Suture material coated with antibiotics or other antimicrobial agents may also be provided with the suturing devices of the present invention.
An exemplary suture material is TEVDEK II®, a braided polyester suture material that is impregnated with PTFE and manufactured by Genzyme Biosurgery of Cambridge, Mass. An exemplary monofilament suture material is DEKLENE II®, a polypropylene suture material also manufactured by Genzyme Biosurgery. Another exemplary monofilament suture material is nylon monofilament, also manufactured by Genzyme Biosurgery. While braided polyester and monofilament polypropylene or nylon are suitable suture materials that may be used with the devices of the present invention, monofilament suture materials may require post-manufacturing processing in order to form the pre-tied knot of the embodiments described with reference to
Monofilament suture material tends to be stiffer relative to braided suture material. As such, forming a bight of suture for the purpose of providing a pre-tied knot is more difficult with monofilament suture than with the more flexible braided suture. The monofilament suture material can tend to straighten itself out after being looped to form a bight 80 (shown in FIGS. 11Ai and 11Aii). Therefore, in order to provide a bight of monofilament suture that is releasably disposed on the shaft of the device without unravelling, such as shown in FIGS. 11Ai and 11Aii,
A method of forming a pretied knot for a suturing device of the present invention includes providing a length of monofilament suture having a first end, wrapping a portion of the length of monofilament suture around a mandrel to form a looped configuration spaced from the first end, and heating the wrapped portion to a temperature below the melting point of the monofilament suture such that upon removal of the mandrel, the wrapped portion remains in the looped configuration.
The bight of the suture includes at least one loop. The heating of the at least one loop is performed to set the bight in the looped configuration. The temperature is kept below the melting temperature of the suture material, yet is selected to cause the suture to remain in the formed looped configuration after the bight is removed from the heat. The temperature is selected so as not to adversely affect properties such as strength of the suture.
In one exemplary heating process, a length of size 3/0 polypropylene suture is looped around a mandrel to form a bight which is heated at a temperature between about 240° F. to about 260° F., or nominally about 250° F., for about 3 to about 5 seconds. The heat is provided by a blowing heat source such as a heat gun that provides an air flow at a rate of about 10 to about 30 standard cubic feet per hour (scfh), or nominally about 20 scfh. The heating of the formed bight may be accomplished in an oven that is heated to about 200° F. to about 280° F. When the bight is formed using an oven, the amount time that the bight is held in the heat of the oven is approximately 1 minute to about 15 minutes. The specific heating temperatures and times may be selected as appropriate for different suture sizes or types, or different types of bight configurations.
In another embodiment, a monofilament nylon suture material may be provided to form a pre-tied knot in a suturing device of the present invention. The temperature at which a bight formed with size 3/0 nylon suture is heated to set the bight is about 190° F. to about 210° F., and nominally about ° F., for about 3 to about 5 minutes with a blowing heat source such as a heat gun. In an oven, the temperature used at which the bight is set is about 190° F. to about 210° F., or nominally about 200° F. for about 1 minute to about 15 minutes.
The present invention offers surgeons an automated method for delivering a pre-tied knot to an incision formed in a lumen. The present invention minimizes the problems associated with a surgeon manually delivering a knot to an incision site. Thus, the present invention reduces the time required to accurately and precisely place a suture knot in close proximity to an incision formed in a lumen, thereby decreasing both the overall time a patient spends in procedure and the costs associated with the procedure.
While illustrative embodiments of the invention are disclosed herein, it will be appreciated that numerous modifications and other embodiments may be devised by those skilled in the art. For example, the various features of each embodiment may be altered or combined to obtain the desired device or method characteristics. Therefore, it will be understood that the appended claims are intended to cover all such modifications and embodiments that come within the spirit and scope of the present invention.
This is a continuation application of U.S. patent application Ser. No. 11/465,527, filed Aug. 18, 2006, now U.S. Pat. No. 7,842,048, the disclosure of which is incorporated herein by this reference. This application also relates to U.S. patent application Ser. No. 10/357,984, filed Feb. 4, 2003, which is a continuation-in-part of U.S. patent application Ser. No. 10/152,272, filed May 20, 2002, now U.S. Pat. No. 6,984,668, which is a continuation-in-part of U.S. patent application Ser. No. 09/651,344, filed Aug. 29, 2000, now U.S. Pat. No. 7,001,400, which is a division of U.S. patent application Ser. No. 09/262,402, filed on Mar. 4, 1999, now U.S. Pat. No. 6,136,010, the disclosures of each is hereby incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
312408 | Wackerhagen | Feb 1885 | A |
597165 | Hall | Jan 1898 | A |
659422 | Shidler | Oct 1900 | A |
989231 | Davis | Apr 1911 | A |
1574362 | Callahan | Sep 1922 | A |
1625602 | Gould et al. | Apr 1927 | A |
1940351 | Howard | Mar 1933 | A |
2012776 | Roeder | Aug 1935 | A |
2131321 | Hart | Oct 1937 | A |
2127903 | Bowen | Aug 1938 | A |
2371978 | Perham | Mar 1945 | A |
2397823 | Walter | Apr 1946 | A |
RE22857 | Ogburn | Mar 1947 | E |
2595086 | Larzelere | Nov 1948 | A |
2588589 | Tauber | Mar 1952 | A |
2646045 | Priestley | Jul 1953 | A |
2692599 | Creelman | Oct 1954 | A |
2941489 | Fischbein | Jun 1960 | A |
2959172 | Held | Nov 1960 | A |
3033156 | Verlish | May 1962 | A |
3104666 | Hale et al. | Sep 1963 | A |
3197102 | Bates et al. | Jul 1965 | A |
3359983 | Northey | Dec 1967 | A |
3413397 | Bierbaum et al. | Nov 1968 | A |
3422181 | Chirgwin, Jr. | Jan 1969 | A |
3470875 | Johnson | Oct 1969 | A |
3485234 | Stevens | Dec 1969 | A |
3587115 | Shiley | Jun 1971 | A |
3630205 | Listner | Dec 1971 | A |
3653388 | Tenckhoff | Apr 1972 | A |
3665926 | Flores | May 1972 | A |
3776237 | Hill et al. | Dec 1973 | A |
3802438 | Wolvek | Apr 1974 | A |
3820544 | Semm | Jun 1974 | A |
3840017 | Violante | Oct 1974 | A |
3874388 | King et al. | Apr 1975 | A |
3878848 | Hiebert | Apr 1975 | A |
3918455 | Coplan | Nov 1975 | A |
3926194 | Greenberg et al. | Dec 1975 | A |
3939820 | Grayzel | Feb 1976 | A |
3985138 | Jarvik | Oct 1976 | A |
4018228 | Goosen | Apr 1977 | A |
4069825 | Akiyama | Jan 1978 | A |
4109658 | Hughes | Aug 1978 | A |
4128100 | Wendorff | Dec 1978 | A |
4135623 | Thyen | Jan 1979 | A |
4161951 | Scanlan, Jr. | Jul 1979 | A |
4168073 | LaRue | Sep 1979 | A |
4182339 | Hardy, Jr. | Jan 1980 | A |
4185636 | Gabbay et al. | Jan 1980 | A |
4216776 | Downie et al. | Aug 1980 | A |
4217665 | Bex et al. | Aug 1980 | A |
4235177 | Arbuckle | Nov 1980 | A |
4235238 | Ogiu et al. | Nov 1980 | A |
4316469 | Kapitanov | Feb 1982 | A |
4317445 | Robinson | Mar 1982 | A |
4411654 | Boarini et al. | Oct 1983 | A |
4412832 | Kling et al. | Nov 1983 | A |
4437465 | Nomoto et al. | Mar 1984 | A |
4469101 | Coleman et al. | Sep 1984 | A |
4492229 | Grunwald | Jan 1985 | A |
4493323 | Albright et al. | Jan 1985 | A |
4553543 | Amarasinghe | Nov 1985 | A |
4586614 | Ger | May 1986 | A |
4587969 | Gillis | May 1986 | A |
4596559 | Fleischhacker | Jun 1986 | A |
4610248 | Rosenberg | Sep 1986 | A |
4629450 | Suzuki et al. | Dec 1986 | A |
4651733 | Mobin-Uddin | Mar 1987 | A |
4655211 | Sakamoto et al. | Apr 1987 | A |
4702250 | Ovil et al. | Oct 1987 | A |
4723549 | Wholey et al. | Feb 1988 | A |
4738666 | Fuqua | Apr 1988 | A |
4744364 | Kensey | May 1988 | A |
4748982 | Horzewski et al. | Jun 1988 | A |
4782954 | Reynolds | Nov 1988 | A |
4803984 | Narayanan et al. | Feb 1989 | A |
4836205 | Barrett | Jun 1989 | A |
4845851 | Warthen | Jul 1989 | A |
4848341 | Ahmad | Jul 1989 | A |
4852568 | Kensey | Aug 1989 | A |
4890612 | Kensey | Jan 1990 | A |
4898155 | Ovil et al. | Feb 1990 | A |
4911164 | Roth | Mar 1990 | A |
4917089 | Sideris | Apr 1990 | A |
4926860 | Stice et al. | May 1990 | A |
4929246 | Sinofsky | May 1990 | A |
4935027 | Yoon | Jun 1990 | A |
4950285 | Wilk | Aug 1990 | A |
4957498 | Caspari et al. | Sep 1990 | A |
4966600 | Songer et al. | Oct 1990 | A |
4981149 | Yoon et al. | Jan 1991 | A |
4983168 | Moorehead | Jan 1991 | A |
4984581 | Stice | Jan 1991 | A |
5002563 | Pyka et al. | Mar 1991 | A |
5009643 | Reich et al. | Apr 1991 | A |
5021059 | Kensey et al. | Jun 1991 | A |
5037433 | Wilk et al. | Aug 1991 | A |
5041129 | Hayhurst et al. | Aug 1991 | A |
5047039 | Avant et al. | Sep 1991 | A |
5059201 | Asnis | Oct 1991 | A |
5061274 | Kensey | Oct 1991 | A |
5074874 | Yoon et al. | Dec 1991 | A |
5078721 | McKeating | Jan 1992 | A |
5080664 | Jain | Jan 1992 | A |
5100419 | Ehlers | Mar 1992 | A |
5100422 | Berguer et al. | Mar 1992 | A |
5100432 | Matsutani | Mar 1992 | A |
5108421 | Fowler | Apr 1992 | A |
5109780 | Slouf et al. | May 1992 | A |
5129882 | Weldon et al. | Jul 1992 | A |
5129912 | Noda et al. | Jul 1992 | A |
5129913 | Ruppert | Jul 1992 | A |
5144961 | Chen et al. | Sep 1992 | A |
5147373 | Ferzli | Sep 1992 | A |
5156788 | Chesterfield et al. | Oct 1992 | A |
5160339 | Chen et al. | Nov 1992 | A |
5163946 | Li | Nov 1992 | A |
5169041 | Tan | Dec 1992 | A |
5171251 | Bregen et al. | Dec 1992 | A |
5176691 | Pierce | Jan 1993 | A |
5178629 | Kammerer | Jan 1993 | A |
5192294 | Blake, III | Mar 1993 | A |
5192301 | Kamiya et al. | Mar 1993 | A |
5192302 | Kensey et al. | Mar 1993 | A |
5201744 | Jones | Apr 1993 | A |
5207703 | Jain | May 1993 | A |
5211650 | Noda | May 1993 | A |
5217470 | Weston | Jun 1993 | A |
5217485 | Liv et al. | Jun 1993 | A |
5219358 | Bendel et al. | Jun 1993 | A |
5222974 | Kensey et al. | Jun 1993 | A |
5234443 | Phan et al. | Aug 1993 | A |
5234445 | Walker et al. | Aug 1993 | A |
5237985 | Hodgson et al. | Aug 1993 | A |
5242427 | Bilweis | Sep 1993 | A |
5250033 | Evans et al. | Oct 1993 | A |
5250053 | Snyder | Oct 1993 | A |
5250054 | Li | Oct 1993 | A |
5254105 | Haaga | Oct 1993 | A |
5254113 | Wilk | Oct 1993 | A |
5254126 | Filipi et al. | Oct 1993 | A |
5258003 | Ciaglia et al. | Nov 1993 | A |
5259846 | Granger et al. | Nov 1993 | A |
5275616 | Fowler | Jan 1994 | A |
5279311 | Snyder | Jan 1994 | A |
5281236 | Bognato et al. | Jan 1994 | A |
5281237 | Gimpelson | Jan 1994 | A |
5284485 | Kammerer et al. | Feb 1994 | A |
5285945 | Brinkerhoff et al. | Feb 1994 | A |
5289963 | McGarry et al. | Mar 1994 | A |
5290284 | Adair | Mar 1994 | A |
5290297 | Phillips | Mar 1994 | A |
5290310 | Makower et al. | Mar 1994 | A |
5292309 | VanTassel et al. | Mar 1994 | A |
5292327 | Dodd et al. | Mar 1994 | A |
5292332 | Lee | Mar 1994 | A |
5293881 | Green et al. | Mar 1994 | A |
5295993 | Green | Mar 1994 | A |
5300085 | Yock | Apr 1994 | A |
5304184 | Hathaway et al. | Apr 1994 | A |
5304185 | Taylor | Apr 1994 | A |
5306254 | Nash et al. | Apr 1994 | A |
5312024 | Grant et al. | May 1994 | A |
5312423 | Rosenbluth et al. | May 1994 | A |
5318578 | Hasson | Jun 1994 | A |
5320629 | Noda et al. | Jun 1994 | A |
5320632 | Heidmueller | Jun 1994 | A |
5330445 | Haaga | Jul 1994 | A |
5330491 | Walker et al. | Jul 1994 | A |
5334217 | Das | Aug 1994 | A |
5336229 | Noda | Aug 1994 | A |
5336230 | Leichtling et al. | Aug 1994 | A |
5336231 | Adair | Aug 1994 | A |
5342369 | Harryman, II | Aug 1994 | A |
5353974 | Maurizio | Oct 1994 | A |
5354312 | Brinkerhoff et al. | Oct 1994 | A |
5364407 | Poll | Nov 1994 | A |
5364408 | Gordon | Nov 1994 | A |
5368595 | Lewis | Nov 1994 | A |
5368601 | Sauer et al. | Nov 1994 | A |
5374275 | Bradley et al. | Dec 1994 | A |
5374278 | Chesterfield et al. | Dec 1994 | A |
5376096 | Foster | Dec 1994 | A |
5383896 | Gershony et al. | Jan 1995 | A |
5383905 | Golds et al. | Jan 1995 | A |
5385569 | Swor | Jan 1995 | A |
5387221 | Bisgaard | Feb 1995 | A |
5387227 | Grice | Feb 1995 | A |
5391176 | de la Torre | Feb 1995 | A |
5391182 | Chin | Feb 1995 | A |
5395332 | Ressemann et al. | Mar 1995 | A |
5395349 | Quiachon et al. | Mar 1995 | A |
5397310 | Chu et al. | Mar 1995 | A |
5397325 | Delia Badia et al. | Mar 1995 | A |
5397326 | Mangum | Mar 1995 | A |
5403329 | Hinchcliffe | Apr 1995 | A |
5403331 | Chesterfield et al. | Apr 1995 | A |
5403338 | Milo | Apr 1995 | A |
5405352 | Weston | Apr 1995 | A |
5411481 | Allen et al. | May 1995 | A |
5413571 | Katsaros et al. | May 1995 | A |
5417684 | Jackson et al. | May 1995 | A |
5417699 | Klein et al. | May 1995 | A |
5419765 | Weldon et al. | May 1995 | A |
5425705 | Evard et al. | Jun 1995 | A |
5425737 | Burbank et al. | Jun 1995 | A |
5425740 | Hutchinson, Jr. | Jun 1995 | A |
5431666 | Sauer et al. | Jul 1995 | A |
5433700 | Peters | Jul 1995 | A |
5452733 | Sterman et al. | Sep 1995 | A |
5454822 | Schob et al. | Oct 1995 | A |
5454834 | Boebel et al. | Oct 1995 | A |
5458574 | Machold et al. | Oct 1995 | A |
5462560 | Stevens | Oct 1995 | A |
5462561 | Voda | Oct 1995 | A |
5464426 | Bonutti | Nov 1995 | A |
5466241 | Leroy et al. | Nov 1995 | A |
5470338 | Whitfield et al. | Nov 1995 | A |
5474568 | Scott | Dec 1995 | A |
5476469 | Hathaway et al. | Dec 1995 | A |
5476470 | Fitzgibbons, Jr. | Dec 1995 | A |
5478309 | Sweezer et al. | Dec 1995 | A |
5478353 | Yoon | Dec 1995 | A |
5480407 | Wan et al. | Jan 1996 | A |
5486190 | Green | Jan 1996 | A |
5489295 | Piplani et al. | Feb 1996 | A |
5496332 | Sierra et al. | Mar 1996 | A |
5507744 | Tay et al. | Apr 1996 | A |
5507755 | Gresl et al. | Apr 1996 | A |
5507757 | Sauer et al. | Apr 1996 | A |
5507758 | Thomason et al. | Apr 1996 | A |
5509902 | Raulerson | Apr 1996 | A |
5520655 | Davila et al. | May 1996 | A |
5520665 | Fleetwood | May 1996 | A |
5520691 | Branch | May 1996 | A |
5520702 | Sauer et al. | May 1996 | A |
5527321 | Hinchliffe | Jun 1996 | A |
5527322 | Klein et al. | Jun 1996 | A |
D372310 | Hartnett | Jul 1996 | S |
5531700 | Moore et al. | Jul 1996 | A |
5536273 | Lehrer | Jul 1996 | A |
5540701 | Sharkey et al. | Jul 1996 | A |
5540703 | Barker, Jr. et al. | Jul 1996 | A |
5540704 | Gordon et al. | Jul 1996 | A |
5545171 | Sharkey et al. | Aug 1996 | A |
5545178 | Kensey et al. | Aug 1996 | A |
5545180 | Le et al. | Aug 1996 | A |
5549618 | Fleenor et al. | Aug 1996 | A |
5549631 | Bonutti | Aug 1996 | A |
5554162 | DeLange | Sep 1996 | A |
5562684 | Kammerer | Oct 1996 | A |
5562686 | Sauer et al. | Oct 1996 | A |
5562688 | Riza | Oct 1996 | A |
5562728 | Lazarus et al. | Oct 1996 | A |
5567435 | Hubbell et al. | Oct 1996 | A |
5569269 | Hart et al. | Oct 1996 | A |
5569271 | Hoel | Oct 1996 | A |
5571120 | Yoon | Nov 1996 | A |
5573540 | Yoon | Nov 1996 | A |
5584842 | Fogarty et al. | Dec 1996 | A |
5591177 | Lehrer | Jan 1997 | A |
5591179 | Edelstein | Jan 1997 | A |
5591206 | Moufarrege | Jan 1997 | A |
5593421 | Bauer | Jan 1997 | A |
5601572 | Middleman et al. | Feb 1997 | A |
5603718 | Xu | Feb 1997 | A |
5607435 | Sachdeva et al. | Mar 1997 | A |
5609597 | Lehrer | Mar 1997 | A |
5611794 | Sauer et al. | Mar 1997 | A |
5613974 | Andreas et al. | Mar 1997 | A |
5613975 | Christy | Mar 1997 | A |
5624446 | Harryman, II | Apr 1997 | A |
5626588 | Sauer et al. | May 1997 | A |
5643289 | Sauer et al. | Jul 1997 | A |
5643295 | Yoon | Jul 1997 | A |
5643318 | Tsukernik et al. | Jul 1997 | A |
5649959 | Hannam et al. | Jul 1997 | A |
5662664 | Gordon et al. | Sep 1997 | A |
5669917 | Sauer et al. | Sep 1997 | A |
5676689 | Kensey et al. | Oct 1997 | A |
5700273 | Buelna et al. | Dec 1997 | A |
5707379 | Fleenor et al. | Jan 1998 | A |
5713910 | Gordon et al. | Feb 1998 | A |
5716369 | Riza | Feb 1998 | A |
5720574 | Barella | Feb 1998 | A |
5720757 | Hathaway et al. | Feb 1998 | A |
5722981 | Stevens | Mar 1998 | A |
5725552 | Kotula et al. | Mar 1998 | A |
5728109 | Schulze et al. | Mar 1998 | A |
5728114 | Evans et al. | Mar 1998 | A |
5728133 | Kontos | Mar 1998 | A |
5728151 | Garrison et al. | Mar 1998 | A |
5741276 | Poloyko et al. | Apr 1998 | A |
5741280 | Fleenor | Apr 1998 | A |
5746755 | Wood et al. | May 1998 | A |
5749890 | Shaknovich | May 1998 | A |
5755727 | Kontos | May 1998 | A |
5759188 | Yoon | Jun 1998 | A |
5766183 | Sauer | Jun 1998 | A |
5766186 | Faraz et al. | Jun 1998 | A |
5766217 | Christy | Jun 1998 | A |
5769862 | Kammerer et al. | Jun 1998 | A |
5779719 | Klein et al. | Jul 1998 | A |
5782860 | Epstein et al. | Jul 1998 | A |
5782861 | Cragg et al. | Jul 1998 | A |
5792151 | Heck et al. | Aug 1998 | A |
5792152 | Klein et al. | Aug 1998 | A |
5797928 | Kogasaka | Aug 1998 | A |
5797929 | Andreas et al. | Aug 1998 | A |
5799661 | Boyd et al. | Sep 1998 | A |
5810849 | Kontos | Sep 1998 | A |
5810850 | Hathaway et al. | Sep 1998 | A |
5814069 | Schulze et al. | Sep 1998 | A |
5817113 | Gifford, III et al. | Oct 1998 | A |
5820631 | Nobles | Oct 1998 | A |
5824010 | McDonald | Oct 1998 | A |
5824111 | Schall et al. | Oct 1998 | A |
5830125 | Scribner et al. | Nov 1998 | A |
5836955 | Buelna et al. | Nov 1998 | A |
5836956 | Buelna et al. | Nov 1998 | A |
5846253 | Buelna et al. | Dec 1998 | A |
5848714 | Robson et al. | Dec 1998 | A |
5855585 | Kontos | Jan 1999 | A |
5860963 | Azam et al. | Jan 1999 | A |
5860990 | Nobles et al. | Jan 1999 | A |
5860991 | Klein et al. | Jan 1999 | A |
5861005 | Kontos | Jan 1999 | A |
5871490 | Schulze et al. | Feb 1999 | A |
5871502 | Suryadevara | Feb 1999 | A |
5873876 | Christy | Feb 1999 | A |
5876411 | Kontos | Mar 1999 | A |
5897487 | Ouchi | Apr 1999 | A |
5897564 | Schulze et al. | Apr 1999 | A |
5902311 | Andreas et al. | May 1999 | A |
5904597 | Doi et al. | May 1999 | A |
5904690 | Middleman et al. | May 1999 | A |
5904697 | Gifford, III et al. | May 1999 | A |
5906631 | Imran | May 1999 | A |
5919207 | Taheri | Jul 1999 | A |
5921994 | Andreas et al. | Jul 1999 | A |
5928266 | Kontos | Jul 1999 | A |
5951590 | Goldfarb | Sep 1999 | A |
5954732 | Hart et al. | Sep 1999 | A |
5957936 | Yoon et al. | Sep 1999 | A |
5957937 | Yoon | Sep 1999 | A |
5957938 | Zhu et al. | Sep 1999 | A |
5964773 | Greenstein | Oct 1999 | A |
5964782 | Lafontaine et al. | Oct 1999 | A |
5972030 | Garrison et al. | Oct 1999 | A |
5976161 | Kirsch et al. | Nov 1999 | A |
5980539 | Kontos | Nov 1999 | A |
5997555 | Kontos | Dec 1999 | A |
6001109 | Kontos | Dec 1999 | A |
6022372 | Kontos | Feb 2000 | A |
6024747 | Kontos | Feb 2000 | A |
6036699 | Andreas et al. | Mar 2000 | A |
6042601 | Smith | Mar 2000 | A |
6048351 | Gordon et al. | Apr 2000 | A |
6048354 | Lawrence | Apr 2000 | A |
6048357 | Kontos | Apr 2000 | A |
6068603 | Suzuki | May 2000 | A |
6077276 | Kontos | Jun 2000 | A |
6077279 | Kontos | Jun 2000 | A |
6117144 | Nobles et al. | Sep 2000 | A |
6117145 | Wood et al. | Sep 2000 | A |
6126675 | Shchervinsky et al. | Oct 2000 | A |
6132439 | Kontos | Oct 2000 | A |
6132440 | Hathaway et al. | Oct 2000 | A |
6136010 | Modesitt et al. | Oct 2000 | A |
6139556 | Kontos | Oct 2000 | A |
6152936 | Christy et al. | Nov 2000 | A |
6165183 | Kuehn et al. | Dec 2000 | A |
6165204 | Levinson et al. | Dec 2000 | A |
6190396 | Whitin et al. | Feb 2001 | B1 |
6197042 | Ginn et al. | Mar 2001 | B1 |
6206893 | Klein et al. | Mar 2001 | B1 |
6206895 | Levinson | Mar 2001 | B1 |
6245079 | Nobles et al. | Jun 2001 | B1 |
6248124 | Pedros et al. | Jun 2001 | B1 |
6296657 | Brucker | Oct 2001 | B1 |
6348059 | Hathaway et al. | Feb 2002 | B1 |
6355050 | Andreas et al. | Mar 2002 | B1 |
6358258 | Arcia et al. | Mar 2002 | B1 |
6395015 | Borst et al. | May 2002 | B1 |
6428472 | Haas | Aug 2002 | B1 |
6428549 | Kontos | Aug 2002 | B1 |
6436109 | Kontos | Aug 2002 | B1 |
6443963 | Baldwin et al. | Sep 2002 | B1 |
6451031 | Kontos | Sep 2002 | B1 |
6511489 | Field et al. | Jan 2003 | B2 |
6517553 | Klein et al. | Feb 2003 | B2 |
6533812 | Swanson et al. | Mar 2003 | B2 |
6551330 | Bain et al. | Apr 2003 | B1 |
6558399 | Isbell et al. | May 2003 | B1 |
6562052 | Nobles et al. | May 2003 | B2 |
6569185 | Ungs | May 2003 | B2 |
6572629 | Kalloo et al. | Jun 2003 | B2 |
6610072 | Christy et al. | Aug 2003 | B1 |
6623509 | Ginn | Sep 2003 | B2 |
6623510 | Carley et al. | Sep 2003 | B2 |
6632237 | Ben-David et al. | Oct 2003 | B2 |
6641592 | Sauer et al. | Nov 2003 | B1 |
6663655 | Ginn et al. | Dec 2003 | B2 |
6676685 | Pedros et al. | Jan 2004 | B2 |
6695867 | Ginn et al. | Feb 2004 | B2 |
6716228 | Tal | Apr 2004 | B2 |
6743195 | Zucker | Jun 2004 | B2 |
6743259 | Ginn | Jun 2004 | B2 |
6749621 | Pantages et al. | Jun 2004 | B2 |
6749622 | McGuckin, Jr. et al. | Jun 2004 | B2 |
6837906 | Ginn | Jan 2005 | B2 |
6846319 | Ginn et al. | Jan 2005 | B2 |
6890343 | Ginn et al. | May 2005 | B2 |
6896692 | Ginn et al. | May 2005 | B2 |
6911034 | Nobles et al. | Jun 2005 | B2 |
6939357 | Navarro et al. | Sep 2005 | B2 |
6964668 | Modesitt et al. | Nov 2005 | B2 |
6969397 | Ginn | Nov 2005 | B2 |
7001400 | Modesitt et al. | Feb 2006 | B1 |
7029480 | Klein et al. | Apr 2006 | B2 |
7029481 | Burdulis, Jr. et al. | Apr 2006 | B1 |
7048747 | Arcia et al. | May 2006 | B2 |
7063710 | Takamoto et al. | Jun 2006 | B2 |
7083635 | Ginn | Aug 2006 | B2 |
7108710 | Anderson | Sep 2006 | B2 |
7112225 | Ginn | Sep 2006 | B2 |
7160309 | Voss | Jan 2007 | B2 |
7179266 | Kontos | Feb 2007 | B2 |
7229458 | Boecker et al. | Jun 2007 | B2 |
7235087 | Modesitt et al. | Jun 2007 | B2 |
7316704 | Bagaoisan et al. | Jan 2008 | B2 |
7326230 | Ravikumar | Feb 2008 | B2 |
7331979 | Khosravi et al. | Feb 2008 | B2 |
7335220 | Khosravi et al. | Feb 2008 | B2 |
7361183 | Ginn | Apr 2008 | B2 |
7361185 | O'Malley et al. | Apr 2008 | B2 |
7377927 | Burdulis, Jr. et al. | May 2008 | B2 |
7390328 | Modesitt | Jun 2008 | B2 |
7393363 | Ginn | Jul 2008 | B2 |
7442198 | Gellman et al. | Oct 2008 | B2 |
7445626 | Songer et al. | Nov 2008 | B2 |
7449024 | Stafford | Nov 2008 | B2 |
7462188 | McIntosh | Dec 2008 | B2 |
7753923 | St. Goar et al. | Jul 2010 | B2 |
7837696 | Modesitt et al. | Nov 2010 | B2 |
7842047 | Modesitt et al. | Nov 2010 | B2 |
7842048 | Ma | Nov 2010 | B2 |
7842049 | Voss | Nov 2010 | B2 |
7846170 | Modesitt et al. | Dec 2010 | B2 |
7850701 | Modesitt | Dec 2010 | B2 |
7883517 | Pantages | Feb 2011 | B2 |
20010046518 | Sawhney | Nov 2001 | A1 |
20020045908 | Nobles et al. | Apr 2002 | A1 |
20020095164 | Andreas et al. | Jul 2002 | A1 |
20020099389 | Michler et al. | Jul 2002 | A1 |
20020106409 | Sawhney et al. | Aug 2002 | A1 |
20020177876 | Roby et al. | Nov 2002 | A1 |
20030093093 | Modesitt et al. | May 2003 | A1 |
20030195529 | Takamoto et al. | Oct 2003 | A1 |
20040009205 | Sawhney | Jan 2004 | A1 |
20040092964 | Modesitt et al. | May 2004 | A1 |
20040093027 | Fabisiak et al. | May 2004 | A1 |
20040097978 | Modesitt et al. | May 2004 | A1 |
20040127940 | Ginn et al. | Jul 2004 | A1 |
20040143290 | Brightbill | Jul 2004 | A1 |
20040158127 | Okada | Aug 2004 | A1 |
20040158287 | Cragg et al. | Aug 2004 | A1 |
20040167511 | Buehlmann et al. | Aug 2004 | A1 |
20040181238 | Zarbatany et al. | Sep 2004 | A1 |
20040186487 | Klein et al. | Sep 2004 | A1 |
20040191277 | Sawhney et al. | Sep 2004 | A1 |
20040215232 | Belhe et al. | Oct 2004 | A1 |
20040225301 | Roop et al. | Nov 2004 | A1 |
20040267193 | Bagaoisan et al. | Dec 2004 | A1 |
20040267308 | Bagaoisan et al. | Dec 2004 | A1 |
20050059982 | Zung et al. | Mar 2005 | A1 |
20050070923 | McIntosh | Mar 2005 | A1 |
20050075665 | Brenzel et al. | Apr 2005 | A1 |
20050085851 | Fiehler et al. | Apr 2005 | A1 |
20050085854 | Ginn | Apr 2005 | A1 |
20050085855 | Forsberg | Apr 2005 | A1 |
20050121042 | Belhe et al. | Jun 2005 | A1 |
20050149117 | Khosravi et al. | Jul 2005 | A1 |
20050177189 | Ginn et al. | Aug 2005 | A1 |
20050222614 | Ginn et al. | Oct 2005 | A1 |
20050245876 | Khosravi et al. | Nov 2005 | A1 |
20050267528 | Ginn et al. | Dec 2005 | A1 |
20050273137 | Ginn | Dec 2005 | A1 |
20060034930 | Khosravi et al. | Feb 2006 | A1 |
20060047313 | Khanna et al. | Mar 2006 | A1 |
20060079914 | Modesitt et al. | Apr 2006 | A1 |
20060100664 | Pai et al. | May 2006 | A1 |
20060167477 | Arcia et al. | Jul 2006 | A1 |
20060173469 | Klein et al. | Aug 2006 | A1 |
20060253037 | Ginn et al. | Nov 2006 | A1 |
20060253072 | Pai et al. | Nov 2006 | A1 |
20070032798 | Pantages et al. | Feb 2007 | A1 |
20070032801 | Pantages et al. | Feb 2007 | A1 |
20070060950 | Khosravi et al. | Mar 2007 | A1 |
20070123817 | Khosravi et al. | May 2007 | A1 |
20070276410 | McIntosh | Nov 2007 | A1 |
20070282354 | McIntosh | Dec 2007 | A1 |
20080009794 | Bagaoisan et al. | Jan 2008 | A1 |
20080065151 | Ginn | Mar 2008 | A1 |
20080065152 | Carley | Mar 2008 | A1 |
20080287967 | Andreas et al. | Nov 2008 | A1 |
20080319458 | Reynolds | Dec 2008 | A1 |
20090005793 | Pantages et al. | Jan 2009 | A1 |
20090036906 | Stafford | Feb 2009 | A1 |
20090048615 | McIntosh | Feb 2009 | A1 |
20090088779 | Zung et al. | Apr 2009 | A1 |
20090157105 | Zung et al. | Jun 2009 | A1 |
20120053600 | Fortson | Mar 2012 | A1 |
Number | Date | Country |
---|---|---|
912619 | May 1954 | DE |
4210724 | Jul 1993 | DE |
9217932 | Jul 1993 | DE |
4220283 | Dec 1993 | DE |
10211360 | Oct 2003 | DE |
0 140 557 | May 1985 | EP |
0 207 545 | Jan 1987 | EP |
0 474 887 | Mar 1992 | EP |
0 478 358 | Apr 1992 | EP |
0 478 887 | Apr 1992 | EP |
0 542 126 | May 1993 | EP |
0 568 098 | Nov 1993 | EP |
0 589 409 | Mar 1994 | EP |
0 624 343 | Nov 1994 | EP |
0 669 101 | Aug 1995 | EP |
0 669 102 | Aug 1995 | EP |
0 669 103 | Aug 1995 | EP |
0 684 012 | Nov 1995 | EP |
0 812 571 | Dec 1997 | EP |
0 941 698 | Sep 1999 | EP |
1059544 | Mar 1954 | FR |
2768324 | Mar 1999 | FR |
51143386 | Nov 1976 | JP |
5220794 | Feb 1977 | JP |
2119866 | May 1990 | JP |
542161 | Feb 1993 | JP |
820810 | Apr 1981 | SU |
993922 | Feb 1983 | SU |
1093329 | May 1984 | SU |
1174036 | Aug 1985 | SU |
1544383 | Feb 1990 | SU |
1648400 | May 1991 | SU |
WO 8503858 | Sep 1985 | WO |
WO 0135833 | Feb 1994 | WO |
WO 9405213 | Mar 1994 | WO |
WO 9413211 | Jun 1994 | WO |
WO 9427503 | Dec 1994 | WO |
WO 9428801 | Dec 1994 | WO |
WO 9505121 | Feb 1995 | WO |
WO 9513021 | May 1995 | WO |
WO 9525468 | Sep 1995 | WO |
WO 9535065 | Dec 1995 | WO |
WO 9609006 | Mar 1996 | WO |
WO 9700046 | Jan 1997 | WO |
WO 9703613 | Feb 1997 | WO |
WO 9707745 | Mar 1997 | WO |
WO 9710764 | Mar 1997 | WO |
WO 9713461 | Apr 1997 | WO |
WO 9717901 | May 1997 | WO |
WO 9720505 | Jun 1997 | WO |
WO 9727897 | Aug 1997 | WO |
WO 9804195 | Feb 1998 | WO |
WO 9842262 | Oct 1998 | WO |
WO 9947049 | Sep 1999 | WO |
WO 0012013 | Mar 2000 | WO |
WO 0051498 | Sep 2000 | WO |
WO 0069342 | Nov 2000 | WO |
WO 0119259 | Mar 2001 | WO |
WO 0236021 | May 2002 | WO |
WO 02062234 | Aug 2002 | WO |
WO 03003925 | Jan 2003 | WO |
WO 03094748 | Nov 2003 | WO |
WO 03099134 | Dec 2003 | WO |
WO 2005000126 | Jan 2005 | WO |
WO 2005023119 | Mar 2005 | WO |
WO 2005025430 | Mar 2005 | WO |
WO 2005030060 | Apr 2005 | WO |
WO 2005041782 | May 2005 | WO |
WO 2005063129 | Jul 2005 | WO |
WO 2005065549 | Jul 2005 | WO |
WO 2005092204 | Oct 2005 | WO |
WO 2005112782 | Dec 2005 | WO |
WO 2006118877 | Jan 2006 | WO |
WO 2006026116 | Mar 2006 | WO |
WO 2006052611 | May 2006 | WO |
WO 2006052612 | May 2006 | WO |
WO 2006078578 | Jul 2006 | WO |
WO 2006115901 | Nov 2006 | WO |
WO 2006115904 | Nov 2006 | WO |
WO 2007019016 | Feb 2007 | WO |
WO 200781836 | Jul 2007 | WO |
Number | Date | Country | |
---|---|---|---|
20110071552 A1 | Mar 2011 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11465527 | Aug 2006 | US |
Child | 12955863 | US |